Union Pharmaceutical is a market-oriented, innovative high-tech pharmaceut₹ical enterprise that realizes industrial development thro≥ugh R&D innovation and technology transformation.

　　From scientific experiments, lab-scale research a±nd development, to pilot scale up and commercialized production, we have always respected the dγevelopment concept of science and technology to cr₽eate value, and realized the rapid transformation of science and techn‍ology into social productive forces; From a team of scientists to a group of industrial engin♦eering experts, from quality analysis to standard the quality assurance s↑ystem; From EHS system to digital management of key produ​ction posts, we pay great importance to the overall development of talents♥, innovation, environment, health, safety and economic benefits; The company enhances th©e contribution of digital technology to the development and growth of the company by establλishing w multi-platform digital operation management system. Union pharmaceutical is  growing in the transformation and developing in adversity by abiding the concept of int"egrity, innovation, sharing and win-win.

　　The Company's current and future development goals cover the follow ing sectors:

　　1) Pharmaceutical R&D;

　　2) Production of advanced intermediates and APIs in line with GMP quality system;☆

　　3) API quality research and preparation research and development;

　　4) Sales of pharmaceutical intermediates and APIs;

　　5) CDMO service;

　　6) Intelligent medical research and development

　　The company integrates multiple resources and strives to build a large health industry fina≤nce platform company integrating pharmaceutical, intelligent medical, bio pharmaceutical R&amσp;D, industrial production and sales.

　　The chemical reactions involved in the existing pr≈oducts include Foucault reaction, nitration reaction, sulfonation reaction, hydrogenation ☆reaction, fluorination reaction, chlorination reaction, brominatio≈n reaction, diazotization reaction, format reaction, etc.

　　The company plans to establish a synthetic biology R&γamp;D center and a micro chemical process development engineerin€g research center.

　　Union has its own intermediates managed according to the GMP system, API mπanufacturing plants, and CDMO business. He hopes to carry out and strengthen coopera✔tion with relevant partners in various fields and contribute to safeguarding human health.

　　Union Medicine has also been deeply engaged in the field of small molecule nucleoside nucl♣eic acid drugs for many years, with certain accumulation. Wi♥th the development and application of artificial intellige$nce and big data, it is actively accelerating the layout of high-end characte↕ristic APIs, preparing for the development of relevant preδparation varieties, and also laying a solid foundation for the÷ subsequent innovative drug research and development.